STAT

AUGUST 19, 2024

The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments.

Medical Schools 360

Medical Schools Drug Development Pharmaceutical Companies Pharmaceutical Companies 360

STAT

NOVEMBER 18, 2023

It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. Jennifer Doudna and Emmanuelle Charpentier, now Nobelists , published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9.

363

363

STAT

FEBRUARY 12, 2024

Over the past decade, the number of research misconduct allegations reported to the National Institutes of Health has more than doubled, climbing from 74 in 2013 to 169 in 2022. And it’s hardly alone. And scientific sleuths are finding plenty of other problems that don’t always qualify as outright misconduct.

363

363

STAT

OCTOBER 11, 2023

So far this year, there have been 1,384 VC deals struck in the field, the lowest figure since 2013. New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly.

340

340

STAT

APRIL 7, 2024

In 2013, it took an average of 9.9 In some cases, failure to show clinical benefit didn’t stop the FDA from converting accelerated approvals into full approvals, and the authors note the agency’s conversion decisions have increasingly been based on less stringent evidence of a drug’s benefits.

358

358

STAT

DECEMBER 8, 2023

Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics were all started in the 2013-2014 time frame with the same goal of turning the nascent CRISPR gene-editing technology into medicines.

329

329

STAT

MAY 19, 2023

Founded in 2013, Pear was the most prominent company developing prescription digital therapeutics, or Food and Drug Administration-cleared software applications ordered by doctors to treat health conditions. Click Therapeutics, Welt Corp, Harvest Bio, and Nox Health Group each acquired bits of the company for $6.05

348

348

STAT

NOVEMBER 10, 2022

He has been part of the C-suite at Sage Therapeutics since 2013. Longtime Sage Therapeutics executive Jeff Jonas is leaving the biotech company to launch a biotech incubator with global investment giant CBC Group. Sage announced this week that Jonas would leave the company to join a private equity firm. billion deal with Biogen.

265

265

STAT

SEPTEMBER 20, 2024

In 2013, I sat down at my computer and secured the URL t1international.com. I wanted a place where I could collect and share everything I was learning about the global insulin price crisis. I was only 25 years old, and I had already been living with type 1 diabetes for more than two decades.

Diabetes 321

Diabetes Hospitals 321

STAT

DECEMBER 20, 2022

For example, the share of Mexican Americans taking insulin who achieved good blood-sugar control sharply dropped to 10% during the period of 2013 to 2020 from 25% during 1988 to 1994, researchers reported Tuesday in JAMA Network Open. Read the rest…

Diabetes 250

Diabetes 250

STAT

DECEMBER 19, 2024

The lawsuit alleged that, since October 2013, CVS knowingly filled prescriptions for “dangerous and excessive quantities” of controlled substances that lacked a legitimate medical purpose, were not valid, and were not issued in the “usual course of professional practice. Department of Justice.

Controlled Substances 257

Controlled Substances 257

STAT

MAY 7, 2024

The company, which last month pleaded guilty to a misdemeanor, admitted that, from April 2012 through May 2013, some of its sales representatives marketed its medicine, also known as oxymorphone, to doctors by touting the drug as abuse deterrent, as well as resistant to tampering and crushing.

Pharmaceutical Companies 289

Pharmaceutical Companies Pharmaceutical Companies 289

STAT

SEPTEMBER 28, 2023

million from 2013 to 2019, presumably due to the company payments, according to the study, which was published in JAMA Health Forum. Physicians who did not accept payments prescribed Avastin 46% of the time, nearly twice as often as those who accepted payments. As a result, Medicare shelled out an estimated $642.8

314

314

STAT

APRIL 23, 2024

Case in point: Under the seemingly benign title, “Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval,” an article published recently in the Journal of the American Medical Association claims that among “cancer drugs granted accelerated approval from 2013 to 2017, 41% (19/46) did not improve (..)

Drug Development 279

Drug Development 279

STAT

MAY 1, 2023

San Francisco-based Carbon said that Elevance — formerly known as Anthem, which operates the Anthem Blue Cross plan in California — had refused to increase its payment rate in the state beyond 2013 levels, which was “no longer tenable as a livable wage.” ” Continue to STAT+ to read the full story…

233

233

STAT

OCTOBER 12, 2022

A federal law that went into effect in 2013 requires the FDA to identify ingredients needed to satisfy an unmet “clinical need” and to include those on  a list for use by large compounding pharmacies.

Compounding Pharmacies 243

Compounding Pharmacies Compounding 243

STAT

DECEMBER 13, 2022

When it hit the market in 2013, the drug revolutionized the treatment of these cancers and represented a major step forward from chemotherapy and some other drugs at the time. NEW ORLEANS – One of the best therapies for some types of lymphoma and leukemia has been a drug called ibrutinib, made by AbbVie.

Chemotherapy 242

Chemotherapy 242

STAT

MARCH 9, 2023

In the spring of 2013, I had just visited a lab focused on gene and cell therapies at Baylor College of Medicine. Bluebird Bio , which would soon launch a successful IPO , had licensed its technology from the same lab and was about to announce a major collaboration with Celgene and Baylor.

238

238

STAT

JANUARY 17, 2024

Central Texas’ Scott and White was absorbed into Baylor in 2013. Wisconsin’s Marshfield Clinic agreed to merge with Duluth-based Essentia Health in October 2022 after a lengthy string of operating losses, though the merger fell apart recently.

Hospitals 335

Hospitals 335

STAT

MAY 15, 2023

Hospitals ran short of essential treatment medications and were unable to source those drugs from manufacturers or from the outsourcing facilities that had been authorized by Congress in 2013 to “fill the gap” in such situations.

Compounding Pharmacies 246

Compounding Pharmacies Compounding Hospitals 246

STAT

JUNE 18, 2024

based company was founded in 2013 and has raised $60 million to date. Perekupka said Freespira hopes to enroll 2,500 people in its treatment this year — twice last year’s sales — and to double its patients again in 2025 and 2026. The Kirkland, Wash.-based

252

252

STAT

APRIL 5, 2023

are charged with knowingly selling defective lead testing machines between 2013 and 2017 that generated inaccurate results for tens of thousands of children across the country and for clients of at least one international relief organization, federal prosecutors said. Three former executives at Magellan Diagnostics Inc.

223

223

STAT

JANUARY 8, 2024

The two men worked together from 2013 until 2022, when Jonas left to start a biotech incubator with funding from investment giant CBC Group. The VC firm has hired Jeff Jonas, Sage’s former chief executive, and Al Robichaud, Sage’s former chief scientific officer, as partners, the team told STAT exclusively.

Labelling 271

Labelling 271

STAT

AUGUST 24, 2023

Indeed, on July 1, drugmakers raised the wholesale price on over 123 drugs in what’s the largest number of mid-year price hikes since 2013, according to data from drug pricing nonprofit 46brooklyn and the Elsevier Gold Standard Drug Database. Continue to STAT+ to read the full story…

Drug Pricing 241

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 241

STAT

AUGUST 3, 2023

In his 2013 State of the Union address, he laid out a bold vision to fund and accelerate brain research: “If we want to make the best products, we also have to invest in the best ideas.

246

246

STAT

AUGUST 30, 2023

In 2013, Kevan Shokat, a biologist at the University of California, San Francisco, discovered a key chemical vulnerability in a specific subset of mutant oncogenic KRAS that made it possible to design small molecules that would bind to the protein. ” In the last few years, that attitude has sharply turned around.

Drug Development 244

Drug Development 244

STAT

MAY 1, 2024

In late 2013, the FDA had conditionally approved the biopsies as a part of an early feasibility study, which it limited to six patients at the medical center who were getting DBS for treatment-resistant depression.

Documentation 363

Documentation Nursing Homes 363

STAT

NOVEMBER 7, 2023

In August 2013, the FDA made news when it issued cybersecurity guidance for medical devices.

240

240

STAT

JUNE 20, 2023

A 2013 trial of the first iteration of Cologuard, known as DeeP-C, showed the test is 92% sensitive and 87% specific. The new Cologuard test correctly detected cancer 94% of the time, and it correctly returned a negative result 91% of the time, test characteristics known as sensitivity and specificity, respectively.

225

225

pharmaphorum

APRIL 8, 2024

Less than half of the cancer therapies given accelerated approval by the FDA in 2013 to 2017 showed a clinical benefit in a confirmatory trial within the next five years

110

110

STAT

MARCH 29, 2024

From 2013 to 2022, pharmaceutical and device companies made more than 85 million payments totaling $12.1 Financial ties between drug and device makers and some physicians remain pervasive, despite concerns such relationships may influence medical practice , STAT writes, citing a new analysis of payments made over a recent 10-year span.

270

270

The Pharmacist

JUNE 27, 2024

A report from the Food Foundation found the height of five-year olds has been falling since 2013, with UK children now shorter than those in nearly […] The post UK children shorter, more obese and less healthy than 20 years ago appeared first on The Pharmacist.

Diabetes 114

Diabetes 114

The Pharmacist

JANUARY 22, 2025

This brings the total number of people who have accessed the service since it launched in 2013 to almost 1.25m. The pharmacy common ailments service in Wales saw 420,951 patients in the last 12 months, new figures from the Welsh Government have revealed.

114

114

ALiEM - Pharm Pearls

MARCH 5, 2024

2013 May;5(5):330. Phytotherapy Research. 2015;29(8):1112-1116. PMID: 25997859. Srivali N, Cheungpasitporn W, Chongnarungsin D, Edmonds LC. White willow bark induced acute respiratory distress syndrome. N Am J Med Sci. PMID: 23814765. Kuzak N, Brubacher JR, Kennedy JR. Reversal of salicylate-induced euglycemic delirium with dextrose.

Clinical Pharmacology 286

Clinical Pharmacology Adverse Reactions Compounding 286

Med Ed 101

OCTOBER 4, 2023

It’s hard to believe that I have been following pharmacist board certifications and helping pharmacists pass the BCPS exam for over 10 years since I first passed it in 2013! Each year in updating and creating our study materials, I review the content outline and any possible changes in the BCPS exam.

111

111

ALiEM - Pharm Pearls

NOVEMBER 10, 2023

2013 Apr;168(4):726-32. Epub 2013 Feb 16. PMID: 34212341 Lipowicz S, Sekula P, Ingen-Housz-Oro S, Liss Y, Sassolas B, Dunant A, Roujeau JC, Mockenhaupt M. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. doi: 10.1111/bjd.12133. PMID: 23413807.

161

161

European Pharmaceutical Review

FEBRUARY 23, 2024

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. Richard has facilitated AbbVie securing a market capitalisation increase from $54 billion in 2013 to over $300 billion in 2024.

Hospitals 97

Hospitals 97